Literature DB >> 16247473

RING finger-dependent ubiquitination by PRAJA is dependent on TGF-beta and potentially defines the functional status of the tumor suppressor ELF.

T Saha1, D Vardhini, Y Tang, V Katuri, W Jogunoori, E A Volpe, D Haines, A Sidawy, X Zhou, I Gallicano, R Schlegel, B Mishra, L Mishra.   

Abstract

In gastrointestinal cells, biological signals for transforming growth factor-beta (TGF-beta) are transduced through transmembrane serine/threonine kinase receptors that signal to Smad proteins. Smad4, a tumor suppressor, is often mutated in human gastrointestinal cancers. The mechanism of Smad4 inactivation, however, remains uncertain and could be through E3-mediated ubiquitination of Smad4/adaptor protein complexes. Disruption of ELF (embryonic liver fodrin), a Smad4 adaptor protein, modulates TGF-beta signaling. We have found that PRAJA, a RING-H2 protein, interacts with ELF in a TGF-beta-dependent manner, with a fivefold increase of PRAJA expression and a subsequent decrease in ELF and Smad4 expression, in gastrointestinal cancer cell lines (P < 0.05). Strikingly, PRAJA manifests substantial E3-dependent ubiquitination of ELF and Smad3, but not Smad4. Delta-PRAJA, which has a deleted RING finger domain at the C terminus, abolishes ubiquitination of ELF. A stable cell line that overexpresses PRAJA exhibits low levels of ELF in comparison to a Delta-PRAJA stable cell line, where ELF expression is high compared to normal controls. The alteration of ELF and/or Smad4 expression and/or function in the TGF-beta signaling pathway may be induced by enhancement of ELF degradation, which is mediated by a high-level expression of PRAJA in gastrointestinal cancers. In hepatocytes, half-life (t(1/2)) and rate constant for degradation (k(D)) of ELF is 1.91 h and 21.72 min(-1) when coupled with ectopic expression of PRAJA in cells stimulated by TGF-beta, compared to PRAJA-transfected unstimulated cells (t(1/2) = 4.33 h and k(D) = 9.6 min(-1)). These studies reveal a mechanism for tumorigenesis whereby defects in adaptor proteins for Smads, such as ELF, can undergo degradation by PRAJA, through the ubiquitin-mediated pathway.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16247473     DOI: 10.1038/sj.onc.1209123

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  19 in total

Review 1.  Targeting TGF-β signaling in cancer.

Authors:  Lior H Katz; Ying Li; Jiun-Sheng Chen; Nina M Muñoz; Avijit Majumdar; Jian Chen; Lopa Mishra
Journal:  Expert Opin Ther Targets       Date:  2013-05-07       Impact factor: 6.902

Review 2.  Ubiquitin-dependent regulation of TGFbeta signaling in cancer.

Authors:  Luisa Izzi; Liliana Attisano
Journal:  Neoplasia       Date:  2006-08       Impact factor: 5.715

3.  Dependence of serotonergic and other nonadrenergic enteric neurons on norepinephrine transporter expression.

Authors:  Zhishan Li; Marc G Caron; Randy D Blakely; Kara G Margolis; Michael D Gershon
Journal:  J Neurosci       Date:  2010-12-08       Impact factor: 6.167

Review 4.  The roles of E3 ligases in Hepatocellular carcinoma.

Authors:  Zongdong Yu; Hong Li; Jie Zhu; Haibiao Wang; Xiaofeng Jin
Journal:  Am J Cancer Res       Date:  2022-03-15       Impact factor: 6.166

Review 5.  TGF-β signaling in liver and gastrointestinal cancers.

Authors:  L H Katz; M Likhter; W Jogunoori; M Belkin; K Ohshiro; L Mishra
Journal:  Cancer Lett       Date:  2016-03-30       Impact factor: 8.679

Review 6.  Transforming growth factor-beta signaling and ubiquitinators in cancer.

Authors:  Eric Glasgow; Lopa Mishra
Journal:  Endocr Relat Cancer       Date:  2008-03       Impact factor: 5.678

7.  Identification of novel Smad2 and Smad3 associated proteins in response to TGF-beta1.

Authors:  Kimberly A Brown; Amy-Joan L Ham; Cara N Clark; Nahum Meller; Brian K Law; Anna Chytil; Nikki Cheng; Jennifer A Pietenpol; Harold L Moses
Journal:  J Cell Biochem       Date:  2008-10-01       Impact factor: 4.429

8.  Fluorescent oligonucleotides can serve as suitable alternatives to radiolabeled oligonucleotides.

Authors:  Rahul Ballal; Amrita Cheema; Waaqar Ahmad; Eliot M Rosen; Tapas Saha
Journal:  J Biomol Tech       Date:  2009-09

9.  The ubiquitin ligase Praja1 reduces NRAGE expression and inhibits neuronal differentiation of PC12 cells.

Authors:  Jan Teuber; Bettina Mueller; Ryoji Fukabori; Daniel Lang; Anne Albrecht; Oliver Stork
Journal:  PLoS One       Date:  2013-05-22       Impact factor: 3.240

10.  Praja1 ubiquitin ligase facilitates degradation of polyglutamine proteins and suppresses polyglutamine-mediated toxicity.

Authors:  Baijayanti Ghosh; Susnata Karmakar; Mohit Prasad; Atin K Mandal
Journal:  Mol Biol Cell       Date:  2021-06-23       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.